Free tool
Heavily traded stocks
We cover 620 companies whose typical session turns over more than $10.00M. The median market value in the group is $2.62B. Across the group, the median move over the past trading day is −0.27%. 67% of the 612 with a 200-day average trade above it. Price change over the past year runs from −28.3% to +179.1% across the middle 80 percent of the group, with a median of +18.6%. Across the group, 6 companies currently carry a tier A volume signal.
Other lists in this group
Table
620 of 7,336 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Company | $1,189.41 | −2.56% | +10.47% | +62.80% |
| JNJ | Johnson & Johnson | $270.00 | +1.23% | +31.66% | +55.40% |
| ABBV | AbbVie Inc. | $262.90 | −0.11% | +16.53% | +29.36% |
| MRK | Merck & Co., Inc. | $153.10 | +16.14% | +44.89% | +86.85% |
| NVS | Novartis AG | $157.54 | −1.45% | +17.18% | +27.93% |
| AZN.L | AstraZeneca PLC | 12,476.00 GBP | −5.00% | −8.20% | +5.65% |
| AZN | AstraZeneca PLC | $166.27 | −3.60% | −8.27% | +5.09% |
| AZN.ST | AstraZeneca PLC | 1,609.00 SEK | −4.94% | −4.94% | +6.22% |
| AMGN | Amgen Inc. | $440.34 | +12.02% | +36.35% | +56.24% |
| TMO | Thermo Fisher Scientific Inc. | $633.71 | +9.94% | +7.06% | +30.17% |
| NOVO-B.CO | Novo Nordisk A/S | 307.80 DKK | −8.95% | −3.58% | −11.26% |
| NOV.DE | Novo Nordisk A/S | 41.42 EUR | −8.48% | +24.38% | +15.22% |
| NVO | Novo Nordisk A/S | $47.19 | −7.40% | −6.62% | −13.32% |
| ABT | Abbott Laboratories | $114.10 | +6.37% | −7.08% | −11.83% |
| GILD | Gilead Sciences, Inc. | $148.09 | +10.25% | +22.48% | +32.51% |
| PFE | Pfizer Inc. | $28.30 | +12.08% | +16.16% | +18.72% |
| DHR | Danaher Corporation | $215.36 | +8.19% | −6.33% | +5.61% |
| VRTX | Vertex Pharmaceuticals Incorporated | $547.29 | +11.60% | +21.05% | +40.66% |
| BMY | Bristol-Myers Squibb Company | $67.57 | +6.24% | +27.70% | +47.01% |
| ISRG | Intuitive Surgical, Inc. | $370.42 | +2.38% | −34.09% | −21.38% |
| SYK | Stryker Corporation | $329.67 | −4.88% | −5.06% | −15.52% |
| MDT | Medtronic plc | $92.02 | +5.92% | −3.41% | +2.29% |
| SAN.PA | Sanofi | 78.74 EUR | −1.48% | +1.00% | −2.60% |
| SNY | Sanofi | $45.42 | −0.26% | −0.60% | −4.33% |
| MCK | McKesson Corporation | $896.65 | +0.80% | +8.98% | +31.57% |
| GSK | GSK plc | $51.43 | −4.25% | +5.41% | +32.23% |
| GSK.L | GSK plc | 1,905.50 GBP | −5.06% | +4.06% | +30.59% |
| HCA | HCA Healthcare, Inc. | $427.16 | +2.14% | −9.06% | +5.96% |
| ELV | Elevance Health, Inc. | $402.54 | +4.36% | +14.33% | +32.12% |
| EL.PA | EssilorLuxottica Société anonyme | 159.15 EUR | −3.60% | −38.64% | −38.15% |
| REGN | Regeneron Pharmaceuticals, Inc. | $814.79 | +17.21% | +5.24% | +39.36% |
| CI | The Cigna Group | $280.87 | −6.71% | +1.18% | −4.84% |
| 4519.T | Chugai Pharmaceutical Co., Ltd. | 6,953.00 JPY | −1.64% | −18.35% | +9.21% |
| MRK.DE | Merck KGaA | 139.35 EUR | −3.96% | +17.18% | +32.17% |
| BSX | Boston Scientific Corporation | $48.17 | +4.58% | −49.14% | −54.50% |
| ARGX | argenx SE | $1,047.10 | +20.05% | +24.66% | +47.90% |
| COR | Cencora, Inc. | $327.79 | +2.57% | −2.88% | +13.45% |
| MRNA | Moderna, Inc. | $149.66 | +168.18% | +384.96% | +496.25% |
| CSL.AX | CSL Limited | 173.59 AUD | +35.54% | +2.25% | −16.37% |
| TAK | Takeda Pharmaceutical Company Limited | $18.23 | +4.05% | +16.71% | +22.68% |
| 4502.T | Takeda Pharmaceutical Company Limited | 5,791.00 JPY | −0.96% | +19.85% | +36.03% |
| BAYN.DE | Bayer Aktiengesellschaft | 49.26 EUR | +3.29% | +30.00% | +76.91% |
| CAH | Cardinal Health, Inc. | $238.40 | +2.53% | +16.17% | +61.05% |
| 207940.KS | Samsung Biologics Co.,Ltd. | 1,589,000.00 KRW | +7.44% | −5.59% | +2.12% |
| EW | Edwards Lifesciences Corporation | $90.78 | +8.48% | +6.39% | +12.21% |
| BDX | Becton, Dickinson and Company | $190.21 | +14.35% | +24.91% | +25.97% |
| 7741.T | HOYA Corporation | 24,525.00 JPY | +3.20% | +2.32% | +28.99% |
| SHL.DE | Siemens Healthineers AG | 39.70 EUR | +5.75% | −7.90% | −14.18% |
| NTRA | Natera, Inc. | $338.45 | +34.19% | +47.90% | +107.59% |
| HUM | Humana Inc. | $391.06 | +0.60% | +48.61% | +33.14% |
| MDLN | Medline Inc. | $35.64 | −12.02% | −12.26% | −13.07% |
| RVMD | Revolution Medicines, Inc. | $215.44 | +17.18% | +172.64% | +466.35% |
| HLN | Haleon plc | $10.17 | −0.97% | +3.05% | +6.13% |
| HLN.L | Haleon plc | 369.60 GBP | −2.66% | −0.12% | +2.68% |
| TEVA | Teva Pharmaceutical Industries Limited | $37.92 | +19.73% | +22.52% | +110.08% |
| A | Agilent Technologies, Inc. | $155.08 | +10.35% | +12.88% | +31.46% |
| IDXX | IDEXX Laboratories, Inc. | $553.44 | −2.83% | −17.40% | −13.64% |
| IQV | IQVIA Holdings Inc. | $261.51 | +7.64% | +16.04% | +38.51% |
| ONC | BeOne Medicines AG | $375.80 | +13.72% | +20.83% | +25.21% |
| WAT | Waters Corporation | $414.17 | +7.88% | +8.43% | +40.57% |
| 4578.T | Otsuka Holdings Co., Ltd. | 12,260.00 JPY | +6.56% | +35.48% | +57.62% |
| VEEV | Veeva Systems Inc. | $244.91 | +21.72% | +11.58% | −16.58% |
| RPRX | Royalty Pharma plc | $61.80 | +3.05% | +60.57% | +74.00% |
| ALC | Alcon Inc. | $72.67 | +5.15% | −5.89% | −10.24% |
| RMD | ResMed Inc. | $235.69 | +12.79% | −3.22% | −15.77% |
| RMD.AX | ResMed Inc. | 32.47 AUD | +8.27% | −9.89% | −24.75% |
| ILMN | Illumina, Inc. | $224.84 | +16.51% | +67.35% | +125.88% |
| DXCM | DexCom, Inc. | $88.96 | +18.85% | +33.69% | +16.47% |
| GEHC | GE HealthCare Technologies Inc. | $73.31 | +14.35% | −11.40% | −1.15% |
| 4568.T | Daiichi Sankyo Company, Limited | 2,874.50 JPY | −0.42% | −17.47% | −17.94% |
| BIIB | Biogen Inc. | $221.07 | +7.52% | +24.32% | +62.12% |
| CNC | Centene Corporation | $65.47 | +2.44% | +56.70% | +127.01% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $239.00 | −17.13% | −40.28% | −47.38% |
| ZTS | Zoetis Inc. | $77.52 | +0.01% | −37.91% | −49.50% |
| 068270.KS | Celltrion, Inc. | 190,900.00 KRW | +6.06% | −5.73% | +11.19% |
| FRE.DE | Fresenius SE & Co. KGaA | 45.85 EUR | +2.98% | −1.28% | +1.64% |
| BNTX | BioNTech SE | $112.56 | +21.75% | +16.41% | +9.27% |
| MTD | Mettler-Toledo International Inc. | $1,398.46 | +0.73% | −0.92% | +8.81% |
| LH | Labcorp Holdings Inc. | $335.72 | +6.84% | +33.74% | +21.14% |
| INSM | Insmed Incorporated | $124.39 | +19.46% | −29.77% | −7.54% |
| DGX | Quest Diagnostics Incorporated | $245.00 | +3.84% | +42.24% | +38.12% |
| 4503.T | Astellas Pharma Inc. | 2,392.50 JPY | +4.23% | +14.03% | +53.57% |
| ROIV | Roivant Sciences Ltd. | $36.75 | +8.60% | +67.58% | +206.51% |
| PHG | Koninklijke Philips N.V. | $26.99 | +5.64% | +3.59% | +1.27% |
| INCY | Incyte Corporation | $128.12 | −1.39% | +26.33% | +51.01% |
| WST | West Pharmaceutical Services, Inc. | $349.92 | +3.90% | +26.81% | +42.61% |
| 4543.T | Terumo Corporation | 2,557.50 JPY | +7.35% | +13.84% | −2.68% |
| STE | STERIS plc | $236.77 | +2.79% | −5.07% | −4.41% |
| GH | Guardant Health, Inc. | $170.92 | +19.01% | +68.00% | +169.17% |
| THC | Tenet Healthcare Corporation | $274.19 | +4.40% | +37.47% | +50.70% |
| DIM.PA | Sartorius Stedim Biotech S.A. | 194.30 EUR | +13.49% | −6.30% | +11.64% |
| SIG.AX | Sigma Healthcare Limited | 2.59 AUD | −13.09% | −11.26% | −15.21% |
| GMAB | Genmab A/S | $33.75 | +16.38% | +6.07% | +36.20% |
| GMAB.CO | Genmab A/S | 2,196.00 DKK | +17.62% | +9.42% | +36.19% |
| SRT3.DE | Sartorius Aktiengesellschaft | 246.50 EUR | +9.26% | −0.18% | +25.88% |
| VTRS | Viatris Inc. | $16.85 | −5.66% | +37.39% | +66.19% |
| ZBH | Zimmer Biomet Holdings, Inc. | $101.38 | +5.88% | +12.93% | −4.32% |
| MEDP | Medpace Holdings, Inc. | $619.05 | +8.42% | +8.41% | +30.74% |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | 469.60 SEK | −0.76% | +42.13% | +61.26% |
| JAZZ | Jazz Pharmaceuticals plc | $249.29 | −2.97% | +43.97% | +100.35% |
| ASND | Ascendis Pharma A/S | $250.25 | −1.65% | +17.33% | +29.66% |
| IPN.PA | Ipsen S.A. | 166.00 EUR | +1.41% | +42.98% | +40.80% |
| COLO-B.CO | Coloplast A/S | 462.50 DKK | +6.22% | −12.68% | −20.60% |
| NBIX | Neurocrine Biosciences, Inc. | $156.59 | −14.35% | +11.37% | +13.36% |
| SOLV | Solventum Corporation | $91.53 | +6.22% | +15.83% | +25.57% |
| BBIO | BridgeBio Pharma, Inc. | $79.37 | −7.22% | +1.45% | +60.05% |
| 4507.T | Shionogi & Co., Ltd. | 2,892.00 JPY | −5.80% | +2.05% | +15.63% |
| FPH.AX | Fisher & Paykel Healthcare Corporation Limited | 36.47 AUD | +5.19% | +12.67% | +11.27% |
| RDOR3.SA | Rede D'Or São Luiz S.A. | 35.30 BRL | +2.86% | −12.41% | +1.37% |
| ERF.PA | Eurofins Scientific SE | 74.08 EUR | +7.93% | +20.90% | +15.60% |
| 7733.T | Olympus Corporation | 2,162.50 JPY | +16.11% | +8.42% | +27.06% |
| COO | The Cooper Companies, Inc. | $72.68 | +0.86% | −10.39% | −1.93% |
| CRL | Charles River Laboratories International, Inc. | $295.10 | +22.74% | +45.79% | +81.27% |
| EXEL | Exelixis, Inc. | $56.10 | −0.73% | +28.73% | +45.68% |
| RVTY | Revvity, Inc. | $126.35 | +13.31% | +28.91% | +42.93% |
| BAX | Baxter International Inc. | $26.50 | +8.74% | +35.96% | +8.90% |
| PME.AX | Pro Medicus Limited | 181.86 AUD | +10.93% | −18.09% | −39.15% |
| ORNBV.HE | Orion Oyj | 80.80 EUR | −1.76% | +29.38% | +21.01% |
| ICLR | ICON Public Limited Company | $168.93 | −6.27% | −10.46% | −2.91% |
| CORT | Corcept Therapeutics Incorporated | $119.80 | +27.19% | +213.61% | +71.81% |
| PEN | Penumbra, Inc. | $323.05 | +0.96% | +4.41% | +21.02% |
| BMRN | BioMarin Pharmaceutical Inc. | $65.61 | +5.70% | +10.36% | +11.85% |
| FME.DE | Fresenius Medical Care AG | 40.36 EUR | −7.39% | +4.49% | −2.61% |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | 52.70 EUR | +2.53% | +10.68% | +1.80% |
| ELAN | Elanco Animal Health Incorporated | $25.08 | −1.72% | +11.37% | +35.64% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $89.12 | +3.89% | +31.46% | +308.99% |
| FMS | Fresenius Medical Care AG | $23.40 | −5.45% | +3.54% | −3.21% |
| MDGL | Madrigal Pharmaceuticals, Inc. | $538.88 | +0.01% | −9.26% | +26.78% |
| HALO | Halozyme Therapeutics, Inc. | $107.06 | +28.29% | +52.27% | +46.30% |
| TEM | Tempus AI, Inc. | $68.48 | +59.63% | +9.81% | −6.49% |
| SNN | Smith & Nephew plc | $29.30 | −10.01% | −9.54% | −19.49% |
| SN.L | Smith & Nephew plc | 1,068.00 GBP | −12.06% | −12.27% | −22.42% |
| EHC | Encompass Health Corporation | $120.78 | +4.09% | +13.77% | −1.75% |
| DVA | DaVita Inc. | $180.05 | −24.81% | +57.24% | +30.89% |
| SMMT | Summit Therapeutics Inc. | $14.23 | +13.39% | −18.78% | −42.63% |
| TECH | Bio-Techne Corporation | $72.38 | +0.43% | +21.73% | +29.33% |
| BTSG | BrightSpring Health Services, Inc. | $61.35 | −15.33% | +59.77% | +156.37% |
| ALGN | Align Technology, Inc. | $159.14 | −9.37% | +1.99% | +12.09% |
| GMED | Globus Medical, Inc. | $83.10 | +3.13% | −4.81% | +35.10% |
| CYTK | Cytokinetics, Incorporated | $79.20 | −0.31% | +28.30% | +109.36% |
| AXSM | Axsome Therapeutics, Inc. | $207.15 | −11.55% | +15.93% | +69.99% |
| GKOS | Glaukos Corporation | $180.57 | +19.32% | +63.09% | +89.83% |
| KRYS | Krystal Biotech, Inc. | $359.76 | −1.23% | +45.70% | +143.67% |
| MOH | Molina Healthcare, Inc. | $199.63 | −0.35% | +11.86% | +13.35% |
| IONS | Ionis Pharmaceuticals, Inc. | $63.36 | +14.58% | −20.47% | +48.21% |
| PRAX | Praxis Precision Medicines, Inc. | $377.37 | +27.57% | +31.76% | +704.28% |
| UHS | Universal Health Services, Inc. | $178.69 | +7.50% | −18.65% | −1.76% |
| KYMR | Kymera Therapeutics, Inc. | $125.55 | +18.26% | +72.55% | +197.09% |
| ENSG | The Ensign Group, Inc. | $180.63 | −1.37% | +3.89% | +5.01% |
| BIO | Bio-Rad Laboratories, Inc. | $388.64 | +17.41% | +27.31% | +32.71% |
| HSIC | Henry Schein, Inc. | $90.38 | +5.45% | +17.65% | +31.02% |
| RGEN | Repligen Corporation | $180.30 | +24.05% | +9.70% | +51.67% |
| BIM.PA | bioMérieux S.A. | 75.50 EUR | +3.64% | −31.05% | −35.91% |
| APGE | Apogee Therapeutics, Inc. | $134.95 | +0.58% | +78.08% | +257.11% |
| ABVX.PA | ABIVAX Société Anonyme | 102.30 EUR | −5.63% | −11.04% | +48.91% |
| RDY | Dr. Reddy's Laboratories Limited | $12.22 | +4.18% | −11.83% | −14.19% |
| ABVX | ABIVAX Société Anonyme | $116.52 | −6.21% | −12.90% | +46.70% |
| PODD | Insulet Corporation | $143.38 | −14.38% | −49.32% | −57.12% |
| AVTR | Avantor, Inc. | $14.50 | +16.75% | +26.53% | +9.93% |
| PTGX | Protagonist Therapeutics, Inc. | $151.50 | +10.71% | +73.78% | +146.62% |
| NUVL | Nuvalent Inc | $123.96 | 0.00% | +22.93% | +62.83% |
| OSCR | Oscar Health, Inc. | $31.24 | −0.51% | +108.68% | +83.55% |
| TWST | Twist Bioscience Corporation | $150.06 | +69.46% | +363.29% | +451.89% |
| DEMANT.CO | Demant A/S | 284.60 DKK | +0.21% | +33.36% | +17.12% |
| PCVX | Vaxcyte, Inc. | $61.09 | +11.89% | +31.49% | +99.97% |
| IMVT | Immunovant, Inc. | $43.89 | +12.83% | +69.39% | +189.13% |
| QGEN | Qiagen N.V. | $43.36 | +2.55% | −4.05% | −9.65% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $84.84 | +1.17% | +81.55% | +179.08% |
| QIA.DE | Qiagen N.V. | 36.71 EUR | −0.60% | −3.76% | −6.73% |
| HQY | HealthEquity, Inc. | $104.42 | +3.14% | +14.66% | +18.69% |
| BRKR | Bruker Corporation | $57.06 | −9.30% | +18.78% | +70.56% |
| ATR | AptarGroup, Inc. | $135.24 | −1.52% | +11.23% | −1.89% |
| 4151.T | Kyowa Kirin Co., Ltd. | 2,613.00 JPY | −3.33% | +3.94% | +4.01% |
| 4523.T | Eisai Co., Ltd. | 4,792.00 JPY | −6.22% | +1.75% | +7.64% |
| TGTX | TG Therapeutics, Inc. Common Stock | $55.03 | +0.29% | +87.94% | +92.61% |
| TXG | 10x Genomics, Inc. | $64.26 | +36.58% | +286.64% | +358.35% |
| RHC.AX | Ramsay Health Care Limited | 50.09 AUD | +13.17% | +46.21% | +50.11% |
| ALKS | Alkermes plc | $49.16 | −2.65% | +73.96% | +68.07% |
| SYRE | Spyre Therapeutics, Inc. | $93.61 | −6.36% | +206.10% | +446.12% |
| RYTM | Rhythm Pharmaceuticals, Inc. | $111.87 | +3.54% | +6.53% | +9.35% |
| CAI | Caris Life Sciences, Inc. | $26.82 | +72.03% | −0.59% | −29.83% |
| 2413.T | M3, Inc. | 1,796.00 JPY | −9.48% | −12.15% | −17.22% |
| 4528.T | Ono Pharmaceutical Co., Ltd. | 2,462.50 JPY | −1.16% | +14.31% | +54.43% |
| SRRK | Scholar Rock Holding Corporation | $60.04 | +21.61% | +40.28% | +74.18% |
| 6869.T | Sysmex Corporation | 1,915.50 JPY | +14.53% | +26.54% | +3.66% |
| ALK-B.CO | ALK-Abelló A/S | 208.80 DKK | −6.62% | −7.16% | +5.09% |
| HNGE | Hinge Health, Inc. | $90.50 | +20.27% | +98.64% | +56.66% |
| SHL.AX | Sonic Healthcare Limited | 20.12 AUD | −11.44% | −8.60% | −11.84% |
| CHE | Chemed Corporation | $548.56 | +5.98% | +29.61% | +20.79% |
| PACS | PACS Group, Inc. | $44.39 | −5.47% | +12.35% | +274.28% |
| GETI-B.ST | Getinge AB (publ) | 243.30 SEK | +2.18% | +14.56% | +20.89% |
| HIMS | Hims & Hers Health, Inc. | $29.83 | +1.74% | −10.72% | −32.22% |
| CGON | CG Oncology, Inc. | $78.42 | +7.99% | +87.65% | +196.15% |
| 3391.T | Tsuruha Holdings Inc. | 2,379.00 JPY | −8.08% | −16.55% | +5.97% |
| 0126Z0.KS | SAMSUNG EPIS HOLDINGS | 387,000.00 KRW | +9.79% | −45.87% | +15.35% |
| ERAS | Erasca, Inc. | $19.15 | +5.45% | +433.43% | +1112.03% |
| 7747.T | Asahi Intecc Co., Ltd. | 3,876.00 JPY | +4.76% | +30.59% | +53.99% |
| LNTH | Lantheus Holdings, Inc. | $100.82 | −1.77% | +49.87% | +77.38% |
| ORKA | Oruka Therapeutics, Inc. | $99.44 | +9.94% | +251.75% | +555.07% |
| RADL3.SA | Raia Drogasil S.A. | 19.31 BRL | +6.10% | −18.17% | +7.42% |
| HLUN-B.CO | H. Lundbeck A/S | 42.68 DKK | +1.19% | +2.35% | +8.99% |
| 3088.T | MatsukiyoCocokara & Co. | 2,575.00 JPY | −4.35% | −4.12% | −14.74% |
| COH.AX | Cochlear Limited | 136.01 AUD | +11.03% | −47.23% | −53.79% |
| COGT | Cogent Biosciences, Inc. | $36.72 | −9.71% | +5.70% | +196.85% |
| BLTE | Belite Bio, Inc | $156.69 | +0.47% | −1.62% | +144.07% |
| LQDA | Liquidia Corporation | $71.36 | −17.81% | +127.26% | +154.86% |
| CNTA | Centessa Pharmaceuticals plc | $40.50 | 0.00% | +70.96% | +143.24% |
| AMRX | Amneal Pharmaceuticals, Inc. | $17.99 | −4.10% | +42.10% | +92.20% |
| TVTX | Travere Therapeutics, Inc. | $67.12 | +20.05% | +69.84% | +284.86% |
| XENE | Xenon Pharmaceuticals Inc. | $63.79 | −1.77% | +43.38% | +64.11% |
| DNTH | Dianthus Therapeutics, Inc. | $110.76 | +9.01% | +179.13% | +356.93% |
| PTCT | PTC Therapeutics, Inc. Common Stock | $72.69 | −3.58% | −5.28% | +46.02% |
| KNSA | Kiniksa Pharmaceuticals International, plc | $78.68 | −0.96% | +87.31% | +133.47% |
| RDNT | RadNet, Inc. | $76.47 | +20.96% | +7.78% | +7.27% |
| CTEC.L | Convatec Group PLC | 228.80 GBP | −0.78% | −4.49% | −1.95% |
| MIRM | Mirum Pharmaceuticals, Inc. | $98.51 | −12.22% | +26.18% | +31.96% |
| DFTX | Definium Therapeutics, Inc. | $43.77 | +4.31% | +220.89% | +344.37% |
| TFX | Teleflex Incorporated | $138.74 | +3.38% | +13.97% | +8.06% |
| LGND | Ligand Pharmaceuticals Incorporated | $287.85 | −2.85% | +51.41% | +80.92% |
| CRSP | CRISPR Therapeutics AG | $59.23 | +24.56% | +10.15% | +10.65% |
| SECT-B.ST | Sectra AB (publ) | 276.20 SEK | −2.47% | +15.28% | −17.02% |
| SHC | Sotera Health Company | $19.54 | +10.02% | +10.46% | +18.42% |
| MMED | MiniMed Group, Inc. | $19.49 | +10.49% | +5.41% | +5.41% |
| MMSI | Merit Medical Systems, Inc. | $90.54 | +15.65% | +4.73% | −0.28% |
| ACAD | ACADIA Pharmaceuticals Inc. | $29.58 | +13.73% | +12.51% | +11.33% |
| DYN | Dyne Therapeutics, Inc. | $26.36 | +1.78% | +42.49% | +93.26% |
| 326030.KS | SK Biopharmaceuticals Co., Ltd. | 88,400.00 KRW | +16.93% | −28.07% | −11.24% |
| HAE | Haemonetics Corporation | $106.60 | +29.15% | +33.28% | +93.71% |
| EWTX | Edgewise Therapeutics, Inc. | $44.38 | +9.99% | +86.86% | +207.13% |
| LFST | LifeStance Health Group, Inc. | $12.15 | +8.10% | +74.57% | +121.31% |
| CELC | Celcuity Inc. | $95.08 | +15.30% | −5.44% | +90.31% |
| WAY | Waystar Holding Corp. | $24.17 | +2.03% | −22.95% | −34.97% |
| 128940.KS | Hanmi Pharm. Co., Ltd. | 503,000.00 KRW | +56.21% | +13.96% | +66.34% |
| HIK.L | Hikma Pharmaceuticals PLC | 1,640.00 GBP | +0.61% | +7.71% | −9.62% |
| BLLN | BillionToOne, Inc. | $96.22 | −28.00% | +7.76% | −11.68% |
| 000100.KS | Yuhan Corporation | 83,100.00 KRW | +18.21% | −25.94% | −27.54% |
| ICUI | ICU Medical, Inc. | $179.59 | +8.33% | +29.64% | +41.83% |
| NVST | Envista Holdings Corporation | $27.80 | +3.12% | +28.17% | +30.89% |
| ELVN | Enliven Therapeutics, Inc. | $60.87 | +13.22% | +291.67% | +194.32% |
| CON | Concentra Group Holdings Parent, Inc. | $34.95 | +6.91% | +81.01% | +50.93% |
| DOCS | Doximity, Inc. | $24.74 | +15.39% | −42.85% | −63.61% |
| LIVN | LivaNova PLC | $79.97 | −2.58% | +31.88% | +41.56% |
| MANE | Veradermics, Incorporated | $102.80 | −7.84% | +172.32% | +172.32% |
| TNGX | Tango Therapeutics, Inc. | $25.47 | −4.43% | +185.22% | +269.13% |
| RLAY | Relay Therapeutics, Inc. | $19.46 | +6.40% | +137.90% | +445.10% |
| HTFL | Heartflow, Inc. | $48.94 | +91.25% | +68.93% | +40.79% |
| ITGR | Integer Holdings Corporation | $125.19 | +24.72% | +63.05% | +15.84% |
| INDV | Indivior Pharmaceuticals, Inc. | $35.83 | −12.60% | +0.27% | +47.06% |
| ADPT | Adaptive Biotechnologies Corporation | $26.16 | +16.16% | +64.42% | +101.70% |
| ANN.AX | Ansell Limited | 40.00 AUD | +18.89% | +14.92% | +18.41% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $37.08 | +89.67% | +224.69% | +292.38% |
| IRTC | iRhythm Holdings, Inc. | $119.15 | +1.52% | −32.00% | −29.83% |
| 4506.T | Sumitomo Pharma Co., Ltd. | 1,436.50 JPY | +13.47% | −41.63% | −3.59% |
| LEGN | Legend Biotech Corporation | $20.68 | +8.61% | −3.86% | −40.44% |
| IDYA | IDEAYA Biosciences, Inc. | $41.58 | +14.99% | +22.84% | +66.32% |
| VKTX | Viking Therapeutics, Inc. | $34.38 | +1.54% | −2.94% | +29.15% |
| DNLI | Denali Therapeutics Inc. | $24.57 | +2.16% | +51.01% | +57.50% |
| ABCL | AbCellera Biologics Inc. | $12.24 | +131.38% | +256.85% | +181.38% |
| RCUS | Arcus Biosciences, Inc. | $30.76 | +13.72% | +32.07% | +191.29% |
| CPRX | Catalyst Pharmaceuticals Inc | $31.49 | 0.00% | +36.03% | +55.97% |
| MCOV-B.ST | Medicover AB (publ) | 243.50 SEK | +8.22% | +14.97% | −8.20% |
| 000105.KS | Yuhan Corporation | 70,500.00 KRW | +19.09% | −30.38% | −32.04% |
| TLX.AX | Telix Pharmaceuticals Limited | 15.68 AUD | +8.14% | +38.03% | +4.88% |
| CAMX.ST | Camurus AB (publ) | 615.00 SEK | −1.68% | +0.49% | −15.35% |
| 4536.T | Santen Pharmaceutical Co., Ltd. | 1,851.50 JPY | −8.36% | +13.69% | +21.45% |
| 7459.T | MediPal Holdings Corporation | 2,893.50 JPY | −5.56% | +4.92% | +13.38% |
| IOVA | Iovance Biotherapeutics, Inc. | $8.08 | +71.91% | +220.63% | +233.88% |
| OGN | Organon & Co. | $13.77 | +1.85% | +90.95% | +50.67% |
| OPCH | Option Care Health, Inc. | $24.04 | +6.94% | −25.43% | −15.91% |
| VCYT | Veracyte, Inc. Common Stock | $44.29 | −20.41% | +4.48% | +54.81% |
| GPCR | Structure Therapeutics Inc. | $49.35 | +3.05% | −27.55% | +159.74% |
| GRAL | GRAIL, Inc. | $79.59 | +23.55% | −10.44% | +136.66% |
| QURE | uniQure N.V. | $50.95 | +38.98% | +117.83% | +223.49% |
| NHC | National HealthCare Corporation | $225.09 | −2.56% | +73.28% | +103.83% |
| PLSE | Pulse Biosciences, Inc. | $48.10 | +35.61% | +259.22% | +203.47% |
| ZEAL.CO | Zealand Pharma A/S | 326.90 DKK | +7.15% | −28.95% | −25.94% |
| IMNM | Immunome, Inc. | $28.75 | +23.82% | +38.09% | +188.94% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $8.90 | +29.74% | +161.76% | +281.97% |
| NAMS | NewAmsterdam Pharma Company N.V. | $27.40 | −2.07% | −22.16% | +11.97% |
| 3349.T | COSMOS Pharmaceutical Corporation | 6,559.00 JPY | −6.35% | −14.64% | −26.59% |
| MBX | MBX Biosciences, Inc. | $66.76 | +11.16% | +118.53% | +366.53% |
| BEAM | Beam Therapeutics Inc. | $30.19 | +14.83% | +11.24% | +79.06% |
| TMDX | TransMedics Group, Inc. | $92.22 | +20.88% | −24.83% | −21.43% |
| CLDX | Celldex Therapeutics, Inc. | $40.57 | +14.02% | +50.20% | +79.51% |
| IRON | Disc Medicine, Inc. | $82.67 | +10.74% | +4.53% | +37.90% |
| WRBY | Warby Parker Inc. | $25.48 | −2.00% | +12.64% | −3.96% |
| 7649.T | Sugi Holdings Co.,Ltd. | 2,682.50 JPY | −11.53% | −26.40% | −28.60% |
| ARQT | Arcutis Biotherapeutics, Inc. | $25.14 | −11.54% | −13.31% | +60.64% |
| TARS | Tarsus Pharmaceuticals, Inc. | $70.65 | +19.85% | −12.53% | +22.19% |
| ALMS | Alumis Inc. | $23.62 | −12.62% | +163.76% | +380.08% |
| BIOA-B.ST | BioArctic AB (publ) | 345.00 SEK | +6.35% | +11.66% | +12.31% |
| ASKER.ST | Asker Healthcare Group AB (publ) | 74.70 SEK | −7.15% | −8.74% | −24.65% |
| HYPE3.SA | Hypera S.A. | 22.01 BRL | +2.66% | −4.58% | −4.69% |
| AVAH | Aveanna Healthcare Holdings Inc. | $13.62 | +37.71% | +68.56% | +73.50% |
| ZLAB | Zai Lab Limited | $26.03 | +39.80% | +50.20% | −20.06% |
| BKD | Brookdale Senior Living Inc. | $12.20 | −20.62% | +12.55% | +55.61% |
| ALHC | Alignment Healthcare, Inc. | $13.90 | −24.58% | −31.26% | −13.88% |
| ACHC | Acadia Healthcare Company, Inc. | $30.58 | −6.45% | +114.00% | +37.81% |
| SLS | SELLAS Life Sciences Group, Inc. | $13.73 | +36.08% | +215.63% | +615.10% |
| NRIX | Nurix Therapeutics, Inc. | $26.71 | +10.60% | +47.90% | +179.69% |
| 9989.T | Sundrug Co.,Ltd. | 3,715.00 JPY | −6.47% | −11.86% | −17.34% |
| VRDN | Viridian Therapeutics, Inc. | $24.26 | +24.35% | −20.93% | +30.71% |
| ATAI | AtaiBeckley Inc. | $7.39 | +2.92% | +90.96% | +61.71% |
| PRVA | Privia Health Group, Inc. | $21.07 | −15.14% | −10.19% | −3.13% |
| AMBU-B.CO | Ambu A/S | 78.40 DKK | +8.59% | −9.10% | −19.13% |
| WGS | GeneDx Holdings Corp. | $90.29 | +45.90% | −31.76% | −30.11% |
| AXGN | AxoGen, Inc. Common Stock | $51.58 | +25.35% | +66.39% | +219.58% |
| VERA | Vera Therapeutics, Inc. | $36.82 | +10.50% | −24.27% | +67.21% |
| PGEN | Precigen, Inc. | $7.42 | +34.18% | +73.36% | +61.66% |
| CDNA | CareDx, Inc. | $50.96 | +42.55% | +166.25% | +283.45% |
| SUPN | Supernus Pharmaceuticals, Inc. | $44.88 | −5.97% | −9.28% | −0.42% |
| RARE | Ultragenyx Pharmaceutical Inc. | $26.44 | +1.77% | +12.03% | −12.10% |
| PHVS | Pharvaris N.V. | $37.00 | +9.97% | +39.73% | +55.59% |
| BHVN | Biohaven Ltd. | $16.95 | +23.09% | +56.37% | +8.65% |
| TRVI | Trevi Therapeutics, Inc. | $17.92 | −2.77% | +50.71% | +124.00% |
| NEOG | Neogen Corporation | $11.70 | +27.31% | +67.14% | +103.83% |
| 2784.T | Alfresa Holdings Corporation | 2,294.00 JPY | −6.65% | −5.45% | +6.80% |
| RAPP | Rapport Therapeutics, Inc. | $52.50 | +25.12% | +86.77% | +250.70% |
| NKTR | Nektar Therapeutics | $73.77 | +4.24% | +69.90% | +151.95% |
| BCRX | BioCryst Pharmaceuticals, Inc. | $9.83 | +0.92% | +31.07% | +15.38% |
| BAVA.CO | Bavarian Nordic A/S | 218.20 DKK | +23.42% | +13.17% | −7.97% |
| KOD | Kodiak Sciences Inc. | $39.33 | −2.38% | +51.15% | +321.09% |
| PBH | Prestige Consumer Healthcare Inc. | $52.15 | +0.83% | −14.82% | −22.12% |
| ATRC | AtriCure, Inc. | $48.17 | +21.18% | +22.66% | +29.14% |
| NUVB | Nuvation Bio Inc. | $6.96 | +4.04% | −18.88% | +135.93% |
| 3549.T | Kusuri No Aoki Holdings Co., Ltd. | 4,115.00 JPY | −2.00% | −8.02% | +5.23% |
| BHC | Bausch Health Companies Inc. | $6.51 | +44.03% | −9.71% | −10.45% |
| ONT.L | Oxford Nanopore Technologies plc | 183.00 GBP | +62.81% | +42.97% | −2.24% |
| OCUL | Ocular Therapeutix, Inc. | $10.77 | +27.46% | −8.88% | −12.58% |
| GRDN | Guardian Pharmacy Services, Inc. | $37.48 | −10.46% | +26.92% | +45.50% |
| 009420.KS | Hanall Biopharma Co., Ltd. | 64,000.00 KRW | +53.48% | +51.66% | +112.62% |
| UFPT | UFP Technologies, Inc. | $304.57 | +18.02% | +36.33% | +41.94% |
| HRMY | Harmony Biosciences Holdings, Inc. | $39.66 | +10.88% | +6.10% | +4.23% |
| BFLY | Butterfly Network, Inc. | $8.64 | +20.50% | +130.40% | +450.32% |
| COAG | Hemab Therapeutics Holdings, Inc. | $49.19 | +4.08% | +44.68% | +44.68% |
| MLYS | Mineralys Therapeutics, Inc. | $25.89 | −3.93% | −27.50% | +70.22% |
| NEO | NeoGenomics, Inc. | $17.37 | +29.63% | +47.70% | +145.34% |
| CLOV | Clover Health Investments, Corp. | $4.25 | −1.96% | +76.35% | +57.99% |
| ADUS | Addus HomeCare Corporation | $120.71 | +1.25% | +13.26% | +4.50% |
| URGN | UroGen Pharma Ltd. | $45.94 | +12.38% | +102.29% | +135.11% |
| PVLA | Palvella Therapeutics, Inc. | $154.33 | +8.04% | +53.90% | +173.39% |
| AUPH | Aurinia Pharmaceuticals Inc. | $16.54 | +10.56% | +7.75% | +36.58% |
| EKTA-B.ST | Elekta AB (publ) | 56.05 SEK | +14.95% | +0.87% | +26.10% |
| MD | Pediatrix Medical Group, Inc. | $26.95 | +0.34% | +26.59% | +56.87% |
| 302440.KS | SK bioscience Co.,Ltd. | 38,100.00 KRW | +17.23% | −20.62% | −20.29% |
| XRAY | DENTSPLY SIRONA Inc. | $10.93 | −18.98% | −3.02% | −21.61% |
| EXE.TO | Extendicare Inc. | 31.68 CAD | −17.40% | +51.30% | +146.56% |
| VCEL | Vericel Corporation | $42.44 | −9.14% | +19.18% | +18.25% |
| 9987.T | Suzuken Co., Ltd. | 5,048.00 JPY | −6.26% | −18.11% | −12.93% |
| ADMA | ADMA Biologics, Inc. | $9.63 | +9.56% | −46.14% | −44.17% |
| ZBIO | Zenas BioPharma, Inc. | $33.04 | +2.32% | −4.23% | +97.73% |
| ESTA | Establishment Labs Holdings Inc. | $72.45 | −21.16% | +5.24% | +70.71% |
| STOK | Stoke Therapeutics, Inc. | $33.09 | +12.59% | +7.09% | +71.45% |
| GN.CO | GN Store Nord A/S | 94.54 DKK | −2.03% | −13.98% | −18.50% |
| XNCR | Xencor, Inc. Common Stock | $28.44 | +42.41% | +90.62% | +254.61% |
| 008930.KS | Hanmi Science Co., Ltd. | 43,400.00 KRW | +29.36% | +19.84% | +2.80% |
| ZYME | Zymeworks Inc. | $29.31 | +29.61% | +10.09% | +96.28% |
| NVCR | NovoCure Limited | $17.89 | +9.69% | +36.36% | +50.21% |
| ALIF-B.ST | AddLife AB (publ) | 162.30 SEK | +0.87% | +8.17% | −7.20% |
| GNS.L | Genus plc | 2,298.00 GBP | +3.23% | −9.70% | −12.94% |
| SRPT | Sarepta Therapeutics, Inc. | $19.46 | +26.12% | −8.68% | +7.69% |
| PRGO | Perrigo Company plc | $14.76 | +43.30% | +8.65% | −36.05% |
| SEM | Select Medical Holdings Corp | $16.51 | −0.12% | +12.30% | +28.14% |
| AGIO | Agios Pharmaceuticals, Inc. Common Stock | $33.99 | −5.56% | +25.06% | −13.45% |
| CMPS | COMPASS Pathways plc | $14.61 | +34.65% | +123.05% | +209.53% |
| 6960.T | Fukuda Denshi Co., Ltd. | 11,970.00 JPY | +5.37% | +57.28% | +79.12% |
| PGNY | Progyny, Inc. | $26.37 | −14.27% | +2.45% | +14.55% |
| FLRY3.SA | Fleury S.A. | 18.66 BRL | +9.38% | +25.83% | +37.82% |
| TSHA | Taysha Gene Therapies, Inc. | $6.02 | +10.26% | +14.67% | +102.69% |
| IMCR | Immunocore Holdings plc | $37.12 | +10.77% | +9.89% | +13.69% |
| ASTH | Astrana Health, Inc. | $38.61 | +1.69% | +53.09% | +23.71% |
| SNDA | Sonida Senior Living, Inc. | $39.67 | −7.89% | +24.24% | +51.53% |
| NTLA | Intellia Therapeutics, Inc. | $13.19 | +21.12% | +43.21% | +15.50% |
| DMRA | Damora Therapeutics, Inc. | $30.39 | +3.30% | +39.28% | +804.46% |
| SEPN | Septerna, Inc. | $40.25 | +18.49% | +43.85% | +218.81% |
| NEU.AX | Neuren Pharmaceuticals Limited | 20.59 AUD | +20.20% | +8.88% | +5.54% |
| VIR | Vir Biotechnology, Inc. | $11.08 | +25.20% | +86.53% | +111.85% |
| RXRX | Recursion Pharmaceuticals, Inc. | $3.49 | +14.43% | −16.90% | −28.63% |
| SGRY | Surgery Partners, Inc. | $14.04 | −9.88% | −7.99% | −38.48% |
| PSNL | Personalis, Inc. | $17.08 | +43.77% | +117.58% | +257.32% |
| BLFS | BioLife Solutions, Inc. | $37.00 | +15.70% | +54.88% | +45.50% |
| INBX | Inhibrx Biosciences, Inc. | $125.34 | +57.30% | +67.03% | +357.45% |
| LMAT | LeMaitre Vascular, Inc. | $79.61 | −22.18% | −0.22% | −16.20% |
| 4540.T | Tsumura & Co. | 3,828.00 JPY | −5.36% | −5.27% | +10.98% |
| ETON | Eton Pharmaceuticals, Inc. | $62.62 | +34.20% | +285.12% | +262.38% |
| INSP | Inspire Medical Systems, Inc. | $61.80 | +18.91% | −33.02% | −33.04% |
| ATT.ST | Attendo AB (publ) | 117.90 SEK | +7.57% | +49.22% | +80.74% |
| SNDX | Syndax Pharmaceuticals, Inc. | $20.09 | +2.34% | −5.68% | +23.55% |
| FTRE | Fortrea Holdings Inc. | $18.53 | −10.48% | +10.23% | +105.20% |
| ANAB | AnaptysBio, Inc. | $58.00 | +11.30% | +93.55% | +326.47% |
| ANIP | ANI Pharmaceuticals, Inc. | $74.56 | −8.00% | −4.93% | −18.85% |
| MAZE | Maze Therapeutics, Inc. | $29.58 | +6.10% | −25.62% | +113.27% |
| 7716.T | Nakanishi Inc. | 3,155.00 JPY | +5.94% | +58.15% | +52.27% |
| BCAX | Bicara Therapeutics Inc. | $24.73 | −8.00% | +50.98% | +105.74% |
| FBRX | Forte Biosciences, Inc. | $76.99 | +0.44% | +226.09% | +589.87% |
| 8129.T | Toho Holdings Co., Ltd. | 3,927.00 JPY | −9.06% | −14.11% | −24.33% |
| AGL | agilon health, inc. | $95.74 | −3.43% | +468.19% | +194.58% |
| 4DX.AX | 4DMedical Limited | 3.70 AUD | +13.34% | −18.61% | +669.79% |
| XERS | Xeris Biopharma Holdings, Inc. | $8.68 | +5.34% | +18.10% | +8.64% |
| ABSI | Absci Corporation | $9.22 | +29.31% | +155.40% | +261.57% |
| TRAX | First Tracks Biotherapeutics, Inc. | $44.19 | +5.59% | +132.58% | +132.58% |
| HCSG | Healthcare Services Group, Inc. | $22.91 | −3.54% | +32.05% | +47.05% |
| 8086.T | Nipro Corporation | 1,535.50 JPY | −8.00% | +4.31% | +4.28% |
| BONEX.ST | Bonesupport Holding AB (publ) | 224.40 SEK | +1.54% | +26.07% | −28.26% |
| TYRA | Tyra Biosciences, Inc. | $26.22 | −15.09% | −2.13% | +103.57% |
| LBRX | LB Pharmaceuticals Inc | $48.17 | +37.85% | +135.64% | +178.41% |
| AVBP | ArriVent BioPharma, Inc. | $31.14 | +3.87% | +49.71% | +62.10% |
| CNMD | CONMED Corporation | $50.48 | +14.08% | +24.58% | −6.91% |
| INVA | Innoviva, Inc. | $21.24 | −2.61% | +6.89% | +7.06% |
| OMCL | Omnicell, Inc. | $33.45 | −22.30% | −25.90% | +0.66% |
| 4516.T | Nippon Shinyaku Co., Ltd. | 3,588.00 JPY | +1.07% | −34.41% | +19.48% |
| NVAX | Novavax, Inc. | $9.21 | +24.97% | +29.17% | +21.50% |
| 6849.T | Nihon Kohden Corporation | 1,491.00 JPY | −10.13% | −11.05% | −7.26% |
| REPL | Replimune Group, Inc. | $15.88 | +196.82% | +78.43% | +187.16% |
| TNDM | Tandem Diabetes Care, Inc. Common Stock | $21.37 | +20.33% | −0.84% | +74.45% |
| CGEM | Cullinan Therapeutics, Inc. | $22.85 | +30.80% | +125.79% | +188.15% |
| AZTA | Azenta, Inc. | $33.57 | +16.04% | +0.54% | +11.16% |
| OMDA | Omada Health, Inc. | $23.96 | +17.28% | +60.81% | +2.74% |
| SDGR | Schrödinger, Inc. | $19.47 | +27.34% | +8.29% | −1.62% |
| ENOV | Enovis Corporation | $25.25 | −14.46% | −4.75% | −18.60% |
| AMBEA.ST | Ambea AB (publ) | 173.60 SEK | +21.74% | +27.37% | +38.66% |
| ATEC | Alphatec Holdings, Inc. | $9.42 | +1.07% | −54.62% | −41.78% |
| ORIC | ORIC Pharmaceuticals, Inc. | $13.91 | +16.79% | +70.26% | +35.58% |
| KALV | KalVista Pharmaceuticals Inc | $27.00 | 0.00% | +74.64% | +98.68% |
| ANRO | Alto Neuroscience, Inc. | $36.53 | +33.22% | +120.19% | +786.65% |
| 4483.T | JMDC Inc. | 3,440.00 JPY | +5.52% | −11.43% | −17.21% |
| OMER | Omeros Corporation | $18.22 | +61.52% | +11.23% | +328.71% |
| JBIO | Jade Biosciences, Inc. | $21.33 | +8.27% | +50.64% | +168.30% |
| 3148.T | Create SD Holdings Co., Ltd. | 3,410.00 JPY | −3.26% | +3.54% | +1.90% |
| 9627.T | Ain Holdings Inc. | 6,142.00 JPY | −2.57% | −5.73% | +2.85% |
| VITR.ST | Vitrolife AB (publ) | 95.10 SEK | +9.31% | −27.76% | −30.23% |
| 3360.T | Ship Healthcare Holdings, Inc. | 2,350.00 JPY | −8.38% | −8.58% | +8.25% |
| NUTX | Nutex Health Inc. | $195.92 | +31.46% | +32.21% | +118.22% |
| CHEMM.CO | ChemoMetec A/S | 496.80 DKK | +15.59% | −26.35% | −3.94% |
| UPR.L | Uniphar plc | 370.00 GBP | −1.33% | +23.75% | +6.94% |
| AORT | Artivion, Inc. | $27.20 | +0.70% | −38.82% | −37.81% |
| AMN | AMN Healthcare Services, Inc. | $34.24 | −1.30% | +126.46% | +70.26% |
| MLTX | MoonLake Immunotherapeutics | $15.62 | −16.52% | +30.71% | −71.82% |
| MNKD | MannKind Corporation | $4.09 | +4.60% | −26.96% | −9.51% |
| IART | Integra LifeSciences Holdings Corporation | $16.88 | −14.57% | +40.55% | +13.52% |
| VOR | Vor Biopharma Inc. | $23.67 | +18.35% | +103.35% | −40.82% |
| SPI.L | Spire Healthcare Group plc | 237.00 GBP | +1.28% | +40.25% | +7.25% |
| 4544.T | H.U. Group Holdings, Inc. | 3,634.00 JPY | +1.08% | +8.30% | +2.77% |
| SANA | Sana Biotechnology, Inc. | $4.16 | +26.44% | −0.72% | +23.44% |
| CERT | Certara, Inc. | $8.22 | +3.92% | −5.95% | −25.07% |
| 2175.T | SMS Co., Ltd. | 2,391.00 JPY | +0.80% | +80.27% | +54.71% |
| GLUE | Monte Rosa Therapeutics, Inc. | $14.38 | −34.75% | −6.07% | +207.92% |
| BIOG-B.ST | BioGaia AB (publ) | 117.10 SEK | +1.39% | +15.05% | +13.96% |
| CRVS | Corvus Pharmaceuticals, Inc. | $14.73 | +10.67% | +101.23% | +167.82% |
| 4553.T | Towa Pharmaceutical Co., Ltd. | 3,915.00 JPY | −7.56% | +9.34% | +34.65% |
| 6523.T | PHC Holdings Corporation | 1,527.00 JPY | +36.71% | +37.93% | +58.42% |
| PRCT | PROCEPT BioRobotics Corporation | $21.07 | +16.54% | −31.50% | −48.36% |
| CVSG.L | CVS Group plc | 1,296.00 GBP | +3.27% | +1.73% | +2.05% |
| 4887.T | Sawai Group Holdings Co., Ltd. | 1,607.50 JPY | −6.02% | −31.23% | −12.86% |
| AVNS | Avanos Medical Inc | $24.99 | +0.04% | +123.52% | +110.53% |
| USPH | U.S. Physical Therapy, Inc. | $78.27 | −0.92% | +0.55% | −5.67% |
| KURA | Kura Oncology, Inc. | $13.06 | +40.28% | +26.37% | +66.16% |
| JANX | Janux Therapeutics, Inc. | $18.89 | +25.93% | +38.39% | −19.10% |
| TDOC | Teladoc Health, Inc. | $6.33 | −32.37% | −10.21% | −18.22% |
| STAA | STAAR Surgical Company | $22.86 | +0.88% | −3.14% | −16.90% |
| 2160.T | GNI Group Ltd. | 2,879.00 JPY | +25.17% | +25.72% | +8.36% |
| IRMD | IRADIMED CORPORATION | $87.47 | −7.76% | −8.02% | +19.80% |
| 7476.T | AS ONE Corporation | 2,473.00 JPY | −4.18% | +4.62% | +2.31% |
| AVTX | Avalo Therapeutics, Inc. | $20.55 | +5.28% | +20.74% | +112.95% |
| 4547.T | Kissei Pharmaceutical Co., Ltd. | 4,095.00 JPY | −5.54% | −9.37% | −1.28% |
| 006280.KS | GC Biopharma Corp. | 127,100.00 KRW | +12.28% | −19.46% | −2.60% |
| SLDB | Solid Biosciences Inc. | $9.72 | +21.96% | +78.35% | +72.95% |
| CSTL | Castle Biosciences, Inc. | $34.08 | +42.65% | −11.57% | +52.96% |
| 069620.KS | Daewoong Pharmaceutical Co., Ltd | 124,000.00 KRW | +1.56% | −25.30% | −9.51% |
| WVE | Wave Life Sciences, Inc. | $5.23 | −11.21% | −67.21% | −48.12% |
| QDEL | QuidelOrtho Corporation | $14.91 | −10.56% | −48.19% | −46.31% |
| PCRX | Pacira BioSciences, Inc. | $25.90 | −3.39% | +5.89% | −0.88% |
| CADL | Candel Therapeutics, Inc. | $13.28 | +37.19% | +144.12% | +124.70% |
| IMMX | Immix Biopharma, Inc. | $14.07 | +66.71% | +159.12% | +617.86% |
| GERN | Geron Corporation | $1.53 | +5.52% | +15.91% | +8.51% |
| HELP | Cybin D/B/A Helus Pharma | $13.63 | +79.34% | +64.61% | +77.71% |
| 7730.T | Mani, Inc. | 1,607.00 JPY | +5.38% | +10.38% | +29.48% |
| ARDX | Ardelyx, Inc. | $3.83 | −24.68% | −37.72% | −38.13% |
| 4521.T | Kaken Pharmaceutical Co., Ltd. | 3,995.00 JPY | +0.13% | +1.77% | +10.07% |
| OLMA | Olema Pharmaceuticals, Inc. | $10.85 | −6.63% | −57.08% | +89.02% |
| ANNX | Annexon, Inc. | $4.99 | +0.40% | +6.40% | +136.49% |
| XVIVO.ST | Xvivo Perfusion AB (publ) | 278.80 SEK | +9.08% | +53.95% | +59.31% |
| CLYM | Climb Bio Inc | $16.08 | +30.84% | +328.80% | +603.72% |
| 3046.T | JINS HOLDINGS Inc. | 6,230.00 JPY | −9.58% | +14.30% | −22.48% |
| 4587.T | PeptiDream Inc. | 1,107.50 JPY | +16.74% | −31.68% | −27.31% |
| 7780.T | Menicon Co., Ltd. | 1,884.00 JPY | +4.09% | +21.53% | +54.36% |
| BBNX | Beta Bionics, Inc. | $19.34 | +22.41% | −33.88% | +1.95% |
| RIGL | Rigel Pharmaceuticals, Inc. | $46.48 | +20.73% | +11.12% | +16.99% |
| FDMT | 4D Molecular Therapeutics, Inc. | $15.56 | +57.97% | +112.57% | +140.87% |
| COLL | Collegium Pharmaceutical, Inc. | $27.51 | −23.37% | −39.58% | −29.08% |
| 4694.T | BML, Inc. | 3,625.00 JPY | −2.03% | −3.47% | +5.42% |
| ACHV | Achieve Life Sciences, Inc. | $8.27 | +33.82% | +66.40% | +177.52% |
| DYVOX.ST | Dynavox Group AB (publ) | 76.70 SEK | +4.14% | −21.71% | −39.29% |
| OXB.L | Oxford Biomedica plc | 515.00 GBP | −5.68% | −21.37% | −9.81% |
| AMS.L | Advanced Medical Solutions Group plc | 281.50 GBP | +0.36% | +29.14% | +38.01% |
| ESPR | Esperion Therapeutics, Inc. Common Stock | $3.18 | 0.00% | −14.29% | +45.87% |
| SNT.WA | Synektik Spólka Akcyjna | 338.40 PLN | −5.58% | +21.82% | +53.07% |
| MNPR | Monopar Therapeutics Inc. | $113.72 | +4.24% | +72.28% | +226.69% |
| 4588.T | Oncolys BioPharma Inc. | 4,080.00 JPY | +66.46% | +173.09% | +539.50% |
| DRUG | Bright Minds Biosciences Inc. | $76.63 | +6.49% | −8.18% | +76.73% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.